Astellas leaders Biopharma Development Head Marci English, and Patient Centricity Head Anthony Yanni, share how the company has been increasing its focus in ophthalmology. They discuss Astellas’ innovative approach, focusing on addressing unmet patient needs and driving progress in the field with cutting-edge therapies and a deep commitment to improving patient outcomes.